Literature DB >> 3048355

Recessive mechanisms of malignancy.

A R Green1.   

Abstract

It is increasingly recognised that recessive mutations play an important role in the pathogenesis of many forms of malignancy. Some of the affected loci may prove to be recessively-activated proto-oncogenes, but others are now known to be tumorigenic solely by virtue of their loss or inactivation and therefore form a distinct and novel family of tumour genes. Preliminary evidence suggests that such genes are likely to be functionally heterogeneous and to encode molecules involved in the inhibition of cellular proliferation and/or the induction of differentiation. Their further study is likely to illuminate fundamental mechanisms of normal cellular growth and differentiation as well as having important implications for the pathogenesis and management of cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3048355      PMCID: PMC2246761          DOI: 10.1038/bjc.1988.176

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  105 in total

Review 1.  Chronic myelogenous leukemia: recent advances.

Authors:  R E Champlin; D W Golde
Journal:  Blood       Date:  1985-05       Impact factor: 22.113

2.  Hereditary cancer, oncogenes, and antioncogenes.

Authors:  A G Knudson
Journal:  Cancer Res       Date:  1985-04       Impact factor: 12.701

3.  Suppression of tumorigenicity in hybrids of normal and oncogene-transformed CHEF cells.

Authors:  R W Craig; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Suppression of malignancy by cell fusion.

Authors:  H Harris; O J Miller; G Klein; P Worst; T Tachibana
Journal:  Nature       Date:  1969-07-26       Impact factor: 49.962

5.  Defective repair replication of DNA in xeroderma pigmentosum.

Authors:  J E Cleaver
Journal:  Nature       Date:  1968-05-18       Impact factor: 49.962

6.  Type beta transforming growth factor: a bifunctional regulator of cellular growth.

Authors:  A B Roberts; M A Anzano; L M Wakefield; N S Roche; D F Stern; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

7.  Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11.

Authors:  N B Atkin; M C Baker
Journal:  Cancer Genet Cytogenet       Date:  1985-02-15

8.  Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation.

Authors:  A Stoler; N Bouck
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

10.  Developmental expression and tissue distribution of the lethal (2) giant larvae protein of Drosophila melanogaster.

Authors:  C Klämbt; O Schmidt
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  9 in total

Review 1.  Cytogenetic abnormalities in cancer: with special emphasis on tumor heterogeneity.

Authors:  S Pathak
Journal:  Cancer Metastasis Rev       Date:  1990-02       Impact factor: 9.264

2.  A rationalized definition of general tumor suppressor microRNAs excludes miR-34a.

Authors:  Sophie Mockly; Élisabeth Houbron; Hervé Seitz
Journal:  Nucleic Acids Res       Date:  2022-04-26       Impact factor: 19.160

3.  Adenocarcinoma and carcinoid developing spontaneously in the stomach of mutant strains of Mastomys natalensis.

Authors:  H Kumazawa; H Takagi; K Sudo; W Nakamura; S Hosoda
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

4.  Mutator phenotype of Werner syndrome is characterized by extensive deletions.

Authors:  K Fukuchi; G M Martin; R J Monnat
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

5.  Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.

Authors:  M Watatani; K Nagayama; Y Imanishi; K Kurooka; T Wada; H Inui; K Hirai; M Ozaki; M Yasutomi
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

6.  Congenital abnormalities in children with cancer and their relatives: results from a case-control study (IRESCC).

Authors:  J R Mann; H E Dodd; G J Draper; J A Waterhouse; J M Birch; R A Cartwright; A L Hartley; P A McKinney; C A Stiller
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

Review 7.  Functional in vitro assays for the isolation of cell transformation effector and suppressor genes.

Authors:  H Zarbl; C J Kho; M O Boylan; J Van Amsterdam; R C Sullivan; C D Hoemann; V L Afshani
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

8.  Alterations of oncogenes in metastatic tumours of human gastric carcinomas.

Authors:  T Tsujino; K Yoshida; H Nakayama; H Ito; T Shimosato; E Tahara
Journal:  Br J Cancer       Date:  1990-08       Impact factor: 7.640

9.  Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma.

Authors:  D M Eccles; L Brett; A Lessells; L Gruber; D Lane; C M Steel; R C Leonard
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.